We encountered a 59-year-old 
Introduction

Interleukin-6 (IL-6) is a multifunctional cytokine which regulates immune responses, hematopoiesis and acute phase reactions (1). It has been demonstrated that IL-6 plays an important role in the pathogenesis and progression of various malignancies
. In patients with lung cancer, it has been shown that IL-6 is associated with tumor proliferation and its prognosis (7) (8) (9) (10) . (11, 12) . In this disease, dysregulated overproduction of IL-6 has been revealed to be responsible for the clinical abnormalities (12, 13) . The prognosis of MCD has been reported to be poor (11, 12) .
Multicentric Castleman's disease (MCD) is a rare lymphoproliferative disorder characterized by systemic lymphadenopathy and constitutional inflammatory symptoms
Herein, we describe a case of an IL-6-producing giant cell carcinoma of the lung with MCD-like presentation.
Case Report
A 59-year-old man was referred to our hospital for the in (Fig. 1A, B) Fig. 2A, B) . The swelling of multiple mediastinal lymph nodes was found, and the maximum diameter was 4 cm (Fig. 3A) . The microscopic findings of the swollen lymph nodes showed no cancer cells. However, polyclonal proliferation of plasma cells was found in the interfollicular areas, which was confirmed by κ-and λ-light chain staining (Fig. 3B, 3C, and 3D ). Polyclonal plasma cell proliferation was also found in the bone marrow. The microscopic findings of the kidneys revealed proliferation of mesangial matrices and mesangial cells. These findings inferred (Fig. 4A, 
ng/mL
ws i n d i c a t e s wo l l e n l y mp h n o d e s ) . T h e h i s t o l o g i c a l e x a mi n a t i o n s h o we d n o c a n c e r c e l l s , b u t p r o l i f e r a t i o n o f p l a s ma c e l l s ( B ) ( He ma t o x y l i n -E o s i n s t a i n , o r i g i n a l × 4 0 0 ) . P l a s ma c e l l s we r e p o l y c l o n a l , wh i c h wa s c o n f i r me d b y κ -a n d λ -l i g h t c h a i n s t a i n i n g ( C, D) ( C: κ -l i g h t c h a i n s t a i n , o r i g i n a l × 2 0 0 , D: λ -l i g h t c h a i n s t a i n , o r i g i n a l × 2 0 0 ) . multicentric Castleman's disease, in which IL-6 has been reported to have a significant role. Immunohistochemical staining of the tumor with a goat anti-human IL-6 polyclonal antibody (DakoCytomation) was positive in the cancer cells
B). It was also positive in plasma cells of the lymph nodes and the bone marrow, though very few in number.
Discussion
We encountered a case of IL-6-producing lung cancer with MCD-like presentation. In this case, the swelling of lymph nodes demonstrated by radiographic studies was attributed not to metastases, but to polyclonal plasmacytosis, which was determined by pathological examinations. The bone marrow was also involved with polyclonal plasmacytosis, and the kidneys showed evidence of exposure to cytokines.
IL-6 is a pleiotropic cytokine which regulates immune responses, hematopoiesis and acute phase reactions (1 (13, 14) . It has also been demonstrated that IL-6 plays an important role in the pathogenesis and progression of various malignancies (2) (3) (4) (5) (6) . In animal systems, IL-6 appears to induce cancer cachexia (15 (11, 17) . This multicentric form of Castleman's disease, known as MCD, is often refractory to treatment even with corticosteroids or chemotherapy, and consequently the prognosis is poor (11, 12) . The median survival of MCD has been reported to be 29 months (12) . Infections, renal failure, and malignancies including malignant lymphoma and Kaposi's sarcoma, are common causes of death in patients with MCD. Male gender, presence of enlarged mediastinal lymph nodes, and episodic pattern of disease have been revealed to be independent predictors of fatal outcomes (11) .
The pathogenesis of Castleman's disease remains unclear, but has been attributed to dysregulated overproduction of (13) . In fact, in cases of localized Castleman's disease, clinical abnormalities may resolve after excision of the affected lymph nodes (11, 13, 17) . Leakage of locally produced IL-6 into the systemic circulation has been thought to cause systemic manifestations of this disease.
IL-6 from the germinal centers of hyperplastic lymph nodes
Recently, some cases of IL-6-producing lung cancer have been reported (18, 19) . In these cases, marked leukocytosis and thrombocytosis, hypoalbuminemia and increased serum concentrations of C-reactive protein were found, as in the pres-ent case. IL-6 production by cancer cells has been demonstrated to play an important role in tumor proliferation by autocrine stimulation in some cases of lung cancer (9) . An elevated serum IL-6 level has been often found in large cell carcinoma frequently with leukocytosis and elevated levels of acute phase proteins (7, 8) . In these cases, it has been reported that clinical stages were often advanced, and that the patient's prognosis was poor (19) 
